文章名稱引用次數

• The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study47
• The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary45
• The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary34
• Renal toxicities associated with pembrolizumab25
• Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network23
• Frailty and chronic kidney disease: current evidence and continuing uncertainties19
• Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?17
• A comparative analysis of survival of patients on dialysis and after kidney transplantation17
• Cost of hemodialysis in a public sector tertiary hospital of India16
• Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease15